Stock ODTC.D ODONATE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Odonate, Inc.

Equities

ODTC.D

US6760793041

Market Closed - OTC Markets
Other stock markets
 02:44:40 2024-04-25 pm EDT 		5-day change 1st Jan Change
18,810 USD +10.00% Intraday chart for Odonate, Inc. +9.22% +25.40%
2023 North American Morning Briefing : Recession Threat Grows as Further Tightening Likely DJ
2023 North American Morning Briefing : Stock Futures -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Odonate Therapeutics : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-K
PU
ODONATE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
Odonate Announces Expected Delisting of Its Stock
BU
Odonate Therapeutics : Announces Planned Return of Capital to Stockholders through Share Repurchase Plan - Form 8-K
PU
ODONATE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan
BU
Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021
BU
ODONATE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
ODONATE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Odonate Therapeutics : Announces Financial Results for the Three and Six Months Ended June 30, 2021
BU
ODONATE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
ODONATE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
Odonate Therapeutics : Announces Financial Results for the Three Months Ended March 31, 2021
BU
ODONATE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
ODONATE THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits (form 8-K)
AQ
Odonate Therapeutics : Announces Discontinuation of Development of Tesetaxel
BU
Odonate Therapeutics : Corporate Presentation March 2021
PU
Odonate Therapeutics : Announces Financial Results for the Three and Twelve Months Ended December 31, 2020
BU
ODONATE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
ODONATE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ODTC.D Stock
  4. News Odonate, Inc.
  5. Press Releases